Breaking News Instant updates and real-time market news.

SNN

Smith & Nephew

$38.39

-1.78 (-4.43%)

, NUVA

NuVasive

$57.45

7.895 (15.93%)

11:42
02/11/19
02/11
11:42
02/11/19
11:42

Canaccord says sell NuVasive on deal speculation rally, buy Smith & Nephew

Canaccord Genuity analyst Kyle Rose advises investors in the near-term to sell NuVasive (NUVA) into the deal-related strength and add to positions in Smith & Nephew (SNN) on the acquisition speculation selloff. The analyst does not find a potential of NuVasive acquisition by Smith & Nephew "to be compelling." A deal could be disruptive to Smith & Nephew's turnaround in both commercial performance and investor sentiment, Rose told investors earlier in a research note. The analyst admits to being caught off guard by Friday's Financial Times report of deal talks. Not by the idea of M&A speculation, but rather the idea of Smith & Nephew "choosing to utilize nearly all of its acquisition bandwidth on a spine acquisition," says Rose. He believes the spine market "doesn't seem to check the right 'growth' boxes." Further, spine deals are "notoriously challenging" given the importance of the distributor/customer relationship and disruption caused in the commercial channels during integration, he adds. Should the talks progress, Rose believes it would take at least $60 per share, or a 21% premium to Friday's closing price, for NuVasive to seriously consider a deal. Share of NuVasive are up 15%, or $7.64, to $57.19 in midday trading while Smith & Nephew is down 4% to $38.43. From a long-term perspective, the analyst says he would maintain Buy ratings on both stocks should the deal were not to be ultimately consummated.

SNN

Smith & Nephew

$38.39

-1.78 (-4.43%)

NUVA

NuVasive

$57.45

7.895 (15.93%)

  • 06

    Mar

SNN Smith & Nephew
$38.39

-1.78 (-4.43%)

02/11/19
JPMS
02/11/19
NO CHANGE
JPMS
NuVasive does not seem to fit Smith & Nephew deal criteria, says JPMorgan
After hosting a call with management, JPMorgan analyst David Adlington believes Smith & Nephew (SNN) is "clearly setting out its intentions for higher M&A activity from here." However, Friday's report from the Financial Times of discussions with NuVasive (NUVA) don't seem to fit the company's criteria, Adlington tells investors in a research note titled "Feedback from management meeting - M&A clearly on the agenda, but we're not sure it's NuVasive." Further, early investor feedback indicates this deal would not be well received, although it would likely be at least high-single-digit earnings accretive, adds the analyst. Adlington points out the spine market is low growth. There is limited product differentiation, outcomes data is scant and push-back by payers has impacted procedure volumes, contends the analyst. He points out JPMorgan is forecasting 4% revenue growth for NuVasive in the near to mid term.
02/11/19
JEFF
02/11/19
NO CHANGE
Target $68
JEFF
Buy
Smith & Nephew buying NuVasive 'makes some sense,' says Jefferies
A potential acquisition of NuVasive (NUVA) "makes some sense" for Smith & Nephew (SNN) as it adds the number three spine company and adds to growth, Jefferies analyst Raj Denhoy tells investors in a research note. The analyst's model shows accretion in year two with return on invested capital 10% in year five. However, the timing of the reported talks is "strange" given the recent management change at NuVasive, adds the analyst. Further, Denhoy believes questions on if spine and NuVasive are the best places for Smith & Nephew to invest will persist. The analyst keeps a Buy rating on NuVasive with a $68 price target.
02/11/19
CANT
02/11/19
NO CHANGE
Target $50
CANT
Neutral
Smith & Nephew unlikely to acquire NuVasive, says Cantor Fitzgerald
Cantor Fitzgerald analyst Craig Bijou thinks a Smith & Nephew (SNN) acquisition of NuVasive (NUVA) is unlikely as he sees more attractive acquisition targets that would better align with the company's goals. Specifically, there are better potential acquisition targets in end markets adjacent to Smith & Nephew with faster growth that would better leverage the company's existing businesses, Bijou tells investors in a research note. He points out the overall spine market is growing by only 0%-2%, below the market growth of Smith & Nephew's current end markets. However, the analyst expects the Financial Times' report on Friday of deal talks to put pressure on shares of Wright Medical (WMGI). Many investors believe that Smith & Nephew is a potential acquirer of Wright and a NuVasive deal would make that combo unlikely in the near term, Bijou contends. He keeps a Neutral rating on NuVasive with a $50 price target.
02/10/19
PIPR
02/10/19
NO CHANGE
Target $70
PIPR
Overweight
Piper Jaffray does not believe Smith & Nephew, NuVasive deal will occur
Following an article by the Financial Times that indicated Smith & Nephew (SNN) was in talks to acquire NuVasive (NUVA), Piper Jaffray analyst Matt O'Brien says he does not believe this transaction will occur as the spine market does not grow much making it less attractive than other orthopedic segments and the landscape is littered with failed spine deals. The analyst thinks investors in NuVasive should take some profit, and anticipates shares of Wright Medical (WMGI) will trade lower on Monday as the most likely suitor for them would be off the table if a NuVasive deal occurred. Finally, the analyst believes a Smith & Nephew/NuVasive combination would be positive for Globus Medical (GMED) and SeaSpine (SPNE) as they would likely take share in the category. O'Brien reiterates an Overweight rating and $ 70 price target on NuVasive's shares.
NUVA NuVasive
$57.45

7.895 (15.93%)

TODAY'S FREE FLY STORIES

14:25
04/24/19
04/24
14:25
04/24/19
14:25
Conference/Events
SunTrust gov't affairs analysts to hold an analyst/industry conference call »

Analysts hold an…

AMTD

TD Ameritrade

$51.98

-2.3 (-4.24%)

14:23
04/24/19
04/24
14:23
04/24/19
14:23
Recommendations
TD Ameritrade analyst commentary at Deutsche Bank »

TD Ameritrade selloff a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 23

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
04/24/19
04/24
14:17
04/24/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEGN

Aegion

$19.89

0.44 (2.26%)

14:16
04/24/19
04/24
14:16
04/24/19
14:16
Hot Stocks
Aegion names Stephanie Cuskley chair of the board of directors »

Aegion Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 02

    May

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
04/24/19
04/24
14:16
04/24/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWL

Newell Brands

$14.06

-0.105 (-0.74%)

14:15
04/24/19
04/24
14:15
04/24/19
14:15
Options
Newell Brands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 07

    May

BA

Boeing

$375.35

1.31 (0.35%)

14:15
04/24/19
04/24
14:15
04/24/19
14:15
Periodicals
Garuda to swap 737 MAX orders to other Boeing aircraft, NAR reports »

Gardua Indonesia intends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 29

    Apr

  • 29

    May

  • 05

    Jun

AMZN

Amazon.com

$1,909.19

-14.89 (-0.77%)

14:13
04/24/19
04/24
14:13
04/24/19
14:13
Periodicals
Amazon testing program to combat patent infringement, The Information says »

Amazon is testing a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 22

    May

  • 03

    Jun

NWBI

Northwest Bancshares

$17.43

0.05 (0.29%)

14:07
04/24/19
04/24
14:07
04/24/19
14:07
Hot Stocks
Northwest Bancshares director Robert Campana sells almost $200K in shares »

Northwest Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMC

UMC

$2.00

0.075 (3.90%)

14:03
04/24/19
04/24
14:03
04/24/19
14:03
Upgrade
UMC rating change  »

UMC upgraded to Hold from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

JNPR

Juniper

$28.67

0.3 (1.06%)

14:00
04/24/19
04/24
14:00
04/24/19
14:00
Options
Active trading in Juniper weeklies ahead of earnings »

Active trading in Juniper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

14:00
04/24/19
04/24
14:00
04/24/19
14:00
General news
Treasury Action: yields remain at or near the lows of the session »

Treasury Action: yields…

SLAB

Silicon Labs

$107.42

13.79 (14.73%)

13:50
04/24/19
04/24
13:50
04/24/19
13:50
Recommendations
Silicon Labs analyst commentary at Roth Capital »

Silicon Labs price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

APC

Anadarko

$71.63

7.51 (11.71%)

, OXY

Occidental Petroleum

$61.03

-1.32 (-2.12%)

13:48
04/24/19
04/24
13:48
04/24/19
13:48
Hot Stocks
Anadarko confirms receipt of unsolicited proposal from Occidental »

Anadarko Petroleum…

APC

Anadarko

$71.63

7.51 (11.71%)

OXY

Occidental Petroleum

$61.03

-1.32 (-2.12%)

CVX

Chevron

$118.75

-3.25 (-2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    Apr

  • 07

    May

  • 10

    May

  • 14

    May

  • 22

    May

  • 29

    May

NYCB

New York Community Bancorp

$11.34

0.02 (0.18%)

13:40
04/24/19
04/24
13:40
04/24/19
13:40
Options
Aggressive call buying in New York Community Bancorp »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 02

    May

  • 04

    Jun

  • 04

    Jun

  • 11

    Jun

GOOG

Alphabet

$1,259.78

-4.71 (-0.37%)

, GOOGL

Alphabet Class A

$1,266.06

-4.54 (-0.36%)

13:35
04/24/19
04/24
13:35
04/24/19
13:35
Hot Stocks
Google says Google Fit now available on iOS »

Google said in a blog…

GOOG

Alphabet

$1,259.78

-4.71 (-0.37%)

GOOGL

Alphabet Class A

$1,266.06

-4.54 (-0.36%)

AAPL

Apple

$207.60

0.1 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 29

    Apr

  • 30

    Apr

  • 14

    May

  • 03

    Jun

  • 27

    Oct

RIO

Rio Tinto

$59.23

-1.38 (-2.28%)

13:35
04/24/19
04/24
13:35
04/24/19
13:35
Options
Rio Tinto put volume heavy and directionally bearish »

Bearish flow noted in Rio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$24.54

-0.11 (-0.45%)

13:33
04/24/19
04/24
13:33
04/24/19
13:33
Periodicals
Breaking Periodicals news story on Macy's »

Macy's in talks to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

MDSO

Medidata

$89.36

1.74 (1.99%)

, DASTY

Dassault Systemes

$0.00

(0.00%)

13:30
04/24/19
04/24
13:30
04/24/19
13:30
Hot Stocks
Medidata gets second downgrade this week amid reported interest from Dassault »

SunTrust analyst Sandy…

MDSO

Medidata

$89.36

1.74 (1.99%)

DASTY

Dassault Systemes

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 23

    Jun

CMCSA

Comcast

$41.79

-0.19 (-0.45%)

, CMCSK

Comcast

$0.00

(0.00%)

13:28
04/24/19
04/24
13:28
04/24/19
13:28
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

CMCSA

Comcast

$41.79

-0.19 (-0.45%)

CMCSK

Comcast

$0.00

(0.00%)

MMM

3M

$218.64

-0.88 (-0.40%)

ABBV

AbbVie

$78.87

0.22 (0.28%)

MO

Altria Group

$54.57

-0.27 (-0.49%)

UPS

UPS

$113.98

0.38 (0.33%)

BMY

Bristol-Myers

$44.80

-0.52 (-1.15%)

RTN

Raytheon

$185.70

-1.82 (-0.97%)

ITW

Illinois Tool Works

$157.27

-0.65 (-0.41%)

BAX

Baxter

$76.61

0.28 (0.37%)

VLO

Valero

$88.33

-1.95 (-2.16%)

LUV

Southwest

$52.44

-0.37 (-0.70%)

HSY

Hershey

$117.01

0.16 (0.14%)

ROK

Rockwell Automation

$189.18

-0.195 (-0.10%)

HES

Hess Corp.

$66.72

-0.74 (-1.10%)

FCX

Freeport McMoRan

$13.43

-0.025 (-0.19%)

IP

International Paper

$44.45

-0.22 (-0.49%)

DHI

D.R. Horton

$46.43

0.035 (0.08%)

TSCO

Tractor Supply

$103.94

0.73 (0.71%)

MAS

Masco

$39.87

-0.13 (-0.33%)

IVZ

Invesco

$21.54

-0.08 (-0.37%)

CLF

Cleveland-Cliffs

$9.52

0.025 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 28

    Apr

  • 30

    Apr

  • 03

    May

  • 03

    May

  • 03

    May

  • 04

    May

  • 06

    May

  • 06

    May

  • 07

    May

  • 09

    May

  • 09

    May

  • 09

    May

  • 10

    May

  • 13

    May

  • 14

    May

  • 15

    May

  • 15

    May

  • 16

    May

  • 18

    May

  • 18

    May

  • 20

    May

  • 21

    May

  • 22

    May

  • 29

    May

  • 31

    May

  • 05

    Jun

  • 05

    Jun

  • 13

    Nov

V

Visa

$161.18

-0.37 (-0.23%)

, FB

Facebook

$182.06

-1.71 (-0.93%)

13:28
04/24/19
04/24
13:28
04/24/19
13:28
Earnings
Notable companies reporting after market close »

Notable companies…

V

Visa

$161.18

-0.37 (-0.23%)

FB

Facebook

$182.06

-1.71 (-0.93%)

MSFT

Microsoft

$125.06

-0.44 (-0.35%)

PYPL

PayPal

$107.56

0.65 (0.61%)

TSLA

Tesla

$261.16

-2.69 (-1.02%)

NOW

ServiceNow

$242.49

-1.005 (-0.41%)

XLNX

Xilinx

$139.87

2.74 (2.00%)

ORLY

O'Reilly Automotive

$396.31

0.65 (0.16%)

LRCX

Lam Research

$196.94

2.1 (1.08%)

CMG

Chipotle

$704.00

1.61 (0.23%)

SAVE

Spirit Airlines

$57.74

0.26 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 05

    May

  • 07

    May

  • 09

    May

  • 14

    May

  • 14

    May

  • 14

    May

  • 21

    May

  • 22

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

  • 03

    Jun

  • 05

    Jun

  • 08

    Jun

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 23

    Jun

  • 06

    Aug

  • 13

    Nov

VST

Vistra Energy

$26.52

0.095 (0.36%)

13:25
04/24/19
04/24
13:25
04/24/19
13:25
Options
Vistra Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

FB

Facebook

$181.94

-1.83 (-1.00%)

, TWTR

Twitter

$39.73

-0.03 (-0.08%)

13:21
04/24/19
04/24
13:21
04/24/19
13:21
On The Fly
#SocialStocks: Facebook's password breach, Twitter and Snap earnings surprise »

Welcome to…

FB

Facebook

$181.94

-1.83 (-1.00%)

TWTR

Twitter

$39.73

-0.03 (-0.08%)

SNAP

Snap

$11.39

-0.6 (-5.00%)

PINS

Pinterest

$26.69

0.88 (3.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 20

    May

  • 30

    May

  • 03

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
04/24/19
04/24
13:17
04/24/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
04/24/19
04/24
13:16
04/24/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.